NewAmsterdam Pharma Company NV Ordinary Shares
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $3,701 | $3,040 | $32 | $348 |
Gross Profit | 3,701 | 2,540 | -27 | 348 |
EBITDA | -59,694 | -48,379 | -74,864 | -71,941 |
EBIT | -59,783 | -48,441 | -74,923 | -72,005 |
Net Income | -64,135 | -48,441 | -74,923 | -72,005 |
Net Change In Cash | 3,701 | 3,040 | 32 | 348 |
Free Cash Flow | -39,294 | -30,642 | -40,975 | -32,811 |
Cash | 424,151 | 457,607 | 490,002 | 538,407 |
Basic Shares | 123,370 | 121,102 | 114,399 | 119,000 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $22,503 | $45,563 | $14,090 | $102,694 |
Gross Profit | 22,444 | 45,563 | 14,090 | 102,694 |
EBITDA | -242,325 | -241,486 | -176,861 | -22,338 |
EBIT | -242,545 | -241,599 | -176,910 | -22,347 |
Net Income | -203,819 | -241,598 | -176,937 | -22,634 |
Net Change In Cash | 22,503 | 45,563 | 14,090 | 102,694 |
Free Cash Flow | -148,029 | -159,236 | -141,242 | 10,444 |
Cash | 490,002 | 771,743 | 340,450 | 467,728 |
Basic Shares | 114,399 | 94,358 | 82,161 | 18,966 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.52 |
2026-03-31 | -$0.34 |
2025-12-31 | -$0.63 |
2025-09-30 | -$0.41 |